pharma.markets

pharma.markets

  • HOME
  • Imprint

Bioscience

BioNTech Announces New ADS Repurchase Program

28/03/2023 MaP 0

BioNTech SE (Nasdaq: BNTX, “BioNTech” or the “Company”) today announced that it has entered into a new share repurchase program (the “Program”), pursuant to which the […]

Bayer expands global clinical program for darolutamide in prostate cancer

23/03/2023 MaP 0

Bayer expands global clinical program for darolutamide in prostate cancer   Phase III study ARASTEP initiated in hormone-sensitive prostate cancer, in patients with high-risk biochemical […]

Bayer collaborates with Microsoft to unveil new cloud-based enterprise solutions, advancing innovation and transparency in the agri-food industry

14/03/2023 MaP 0

Ready-to-use AgPowered Services from Bayer running on the new Microsoft Azure Data Manager for Agriculture / Readymade capabilities and robust digital infrastructure allow innovators to […]

New organ-on-chip pilot seeks to reduce animal testing in consumer health industry

07/03/2023 MaP 0

Cross-section of organ-on-chip biochip cavities with cells representing intestinal model. A first-of-its-kind collaboration in the consumer health industry is developing a platform aimed at reducing […]

Fruit Logistica 2023: Bayer focuses on partnerships, sustainability, and innovation

08/02/2023 MaP 0

Partnering with players along the food value chain is key to tackle challenges of food security and climate change / Bayer makes substantial progress in […]

CABIO Showcases the Latest Research Results and Innovative Solutions at Food Ingredients Europe 2022

08/12/2022 MaP 0

On December 6, 2022, CABIO Biotech (Wuhan) Co., Ltd (CABIO), a leading Chinese biotechnology company, took part in the three-day Food Ingredients Europe 2022 (Fi […]

Merck Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition

06/12/2022 MaP 0

Merck has acquired Massachusetts-based Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology, known as the “Breez™”. Merck, a leading science and technology […]

BioNTech and Ryvu Therapeutics Enter into Global Collaboration

30/11/2022 MaP 0

…to Develop and Commercialize Immuno-Modulatory Small Molecule Candidates BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Ryvu Therapeutics S.A. (Warsaw Stock Exchange: RVU, “Ryvu”), a clinical-stage company developing […]

APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival

21/11/2022 MaP 0

RELIEF THERAPEUTICS Holding SA (SIX: RLF) (OTCQB: RLFTF) (RLFTD) (“Relief”), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent protected products in selected […]

Merck Invests € 290 Million in U.S. Drug Safety Testing Capacity

16/11/2022 MaP 0

• Responds to growing global demand for biosafety testing as essential requirement for drug development and commercialization • Expansion creates more than 500 new jobs […]

BerGenBio reports third quarter 2022 financial results and provides business update

15/11/2022 MaP 0

– Randomized first patient in the Phase 2b EU-SolidAct platform for hospitalized COVID-19 patients –– Initiated Phase 1b/2a trial in 1st line NSCLC patients harboring STK11 […]

BerGenBio ASA Secures NOK 100 million Shareholder Loan Facility from Meteva AS

25/10/2022 MaP 0

BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, and Meteva AS, a 27.23% shareholder […]

BioNTech to Report Third Quarter 2022 Financial Results and Operational Update on November 7, 2022

24/10/2022 MaP 0

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the third quarter 2022 on Monday, November 7th, 2022. BioNTech invites […]

Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals

23/08/2022 MaP 0

Hovione and Zerion Pharma A/S (Zerion) today announced an extension of their collaboration on Zerion’s Dispersome® technology into the nutraceutical/dietary supplements field. Many dietary supplements suffer […]

Novaliq submits New Drug Application seeking approval for first-of-a-kind Dry Eye Disease Treatment CyclASol®

09/08/2022 MaP 0

Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced the submission of a New […]

Posts navigation

1 2 »

Translation

Search

Categories

  • Age.related Degeneration
  • Alzheimer
  • Animal health
  • Asthma
  • Bioscience
  • Cancer
  • Conferences
  • Cosmetics
  • COVID-19
  • EIB
  • EU
  • FCPA Investigations
  • FDA
  • Finance
  • Food
  • HHS
  • Humanitarian Aid
  • Imprint
  • Influenza
  • Innovation
  • Mental Health
  • MS
  • News
  • Research
  • Rheumatology
  • Space Science
  • Spain
  • Sports
  • Therapy
  • Trade Fair
  • UN
  • Vaccines
  • Valencia Comunidad
  • WHO

Reports

  • SciBase and Schweiger Dermatology Group partner to advance skin cancer detection in select New Jersey locations
  • BioNTech Announces New ADS Repurchase Program
  • Merck Announces Expanded Partnership with Beyond Benign to Increase Global Access to Green Chemistry Education
  • Bayer expands global clinical program for darolutamide in prostate cancer
  • Sandoz receives US FDA approval for biosimilar Hyrimoz® (adalimumab-adaz) high-concentration formulation

Archive

  • March 2023 (18)
  • February 2023 (11)
  • January 2023 (6)
  • December 2022 (16)
  • November 2022 (11)
  • October 2022 (14)
  • September 2022 (1)
  • August 2022 (4)
  • July 2022 (3)
  • June 2022 (8)
  • May 2022 (1)
  • April 2022 (2)
  • March 2022 (5)
  • February 2022 (9)
  • January 2022 (19)
  • December 2021 (37)
  • November 2021 (17)
  • October 2021 (5)
  • August 2021 (5)
  • July 2021 (5)
  • June 2021 (1)
  • May 2021 (6)
  • April 2021 (9)
  • March 2021 (23)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
  • SciBase and Schweiger Dermatology Group partner to advance skin cancer detection in select New Jersey locations

    29/03/2023 0
  • BioNTech Announces New ADS Repurchase Program

    28/03/2023 0
  • Merck Announces Expanded Partnership with Beyond Benign to Increase Global Access to Green Chemistry Education

    27/03/2023 0
  • Bayer expands global clinical program for darolutamide in prostate cancer

    23/03/2023 0
  • Sandoz receives US FDA approval for biosimilar Hyrimoz® (adalimumab-adaz) high-concentration formulation

    21/03/2023 0
Archives
  • March 2023 (18)
  • February 2023 (11)
  • January 2023 (6)
  • December 2022 (16)
  • November 2022 (11)
  • October 2022 (14)
  • September 2022 (1)
  • August 2022 (4)
  • July 2022 (3)
  • June 2022 (8)
  • May 2022 (1)
  • April 2022 (2)
  • March 2022 (5)
  • February 2022 (9)
  • January 2022 (19)
  • December 2021 (37)
  • November 2021 (17)
  • October 2021 (5)
  • August 2021 (5)
  • July 2021 (5)
  • June 2021 (1)
  • May 2021 (6)
  • April 2021 (9)
  • March 2021 (23)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
TAGS
affected africa aid bayer biontech cancer commission companies coronavirus covid-19 covid19 economy elpais.com emergency eu europe european fda food global guarantee health hygiene investment links medical merck novartis pandemic pfizer production recommendations region response roche safety scheme sector spain state statistics support test vaccine who

Copyright © 2023 | WordPress Theme by MH Themes

Cookie Consent with Real Cookie Banner